VOYA Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,102
Closed -$40.7K 2657
2025
Q2
$40.7K Hold
13,102
﹤0.01% 2627
2025
Q1
$44.3K Sell
13,102
-1,886
-13% -$8.81K ﹤0.01% 2565
2024
Q4
$85K Sell
14,988
-1,269
-8% -$8.18K ﹤0.01% 2608
2024
Q3
$95.1K Buy
16,257
+288
+2% +$2.09K ﹤0.01% 2675
2024
Q2
$126K Buy
15,969
+5,815
+57% +$48.7K ﹤0.01% 2610
2024
Q1
$94.5K Sell
10,154
-3,114
-23% -$26.3K ﹤0.01% 2627
2023
Q4
$112K Hold
13,268
﹤0.01% 2729
2023
Q3
$103K Buy
13,268
+584
+5% +$5.33K ﹤0.01% 2724
2023
Q2
$145K Buy
+12,684
New +$131K ﹤0.01% 2689
2021
Q2
Sell
-14,094
Closed -$66K 2906
2021
Q1
$66K Buy
14,094
+3,041
+28% +$20.7K ﹤0.01% 2722
2020
Q4
$79K Buy
+11,053
New +$106K ﹤0.01% 2604
2020
Q2
Sell
-12,312
Closed -$113K 2633
2020
Q1
$113K Hold
12,312
﹤0.01% 2313
2019
Q4
$172K Buy
+12,312
New +$179K ﹤0.01% 2421
2019
Q3
Sell
-9,619
Closed -$262K 2575
2019
Q2
$262K Buy
+9,619
New +$220K ﹤0.01% 2146

Other funds holding VYGR

VOYA Investment Management's VYGR Position: Q3 2025 in Review

VOYA Investment Management sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 13,102 shares — an estimated $40.7K sold.

VOYA Investment Management first reported a position in VYGR in Q2 2019 and held it in 14 quarters. The position peaked at $262K in Q2 2019. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • VOYA Investment Management reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 13,102 Voyager Therapeutics shares in Q3 2025, an estimated $40.7K.
  • VOYA Investment Management first reported a position in Voyager Therapeutics in Q2 2019 and held it in 14 quarters.
  • VOYA Investment Management's Voyager Therapeutics position peaked at $262K in Q2 2019.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.